Flagship Ventures backs Symbiota

Symbiota has closed $7.5 million in Series A funding from Flagship Ventures. Based in Cambridge, Mass., Symbiota is a provider of microbial solutions.

ByIris Dorbian

13 November 2014•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

Flagship Ventures backs Symbiota

Flagship Pioneering

Eisai

Syngenta Pension Fund